La
oficina de proyectos
internacionales del IIS
Aragón ha creado este
boletín mensual mediante
el cual se va a informar
de las convocatorias de
proyectos que se
encuentran abiertas, los
eventos y las jornadas que
puedan resultar
interesantes al respecto
para el personal
investigador y de
gestión.
Si quieres contactar con
la oficina de proyectos
internacionales puedes
hacerlo a través de esta
dirección de correo
electrónico: internacional@iisaragon.es
The
COFUND action
provides funding for
regional, national
and international
programmes for
training and career
development, through
co-funding
mechanisms. It
spreads the MSCA’s
best practices by
promoting high
standards and
excellent working
conditions. COFUND
promotes sustainable
training and
international,
interdisciplinary
and inter-sectoral
mobility.
The
ERC Proof of Concept
Grants aim to
maximise the value
of the excellent
research that the
ERC funds, by
funding further work
(i.e. activities
which were not
scheduled to be
funded by the
original ERC
frontier research
grant) to verify the
innovation potential
of ideas arising
from ERC funded
projects. Proof of
Concept Grants are
therefore on offer
only to Principal
Investigators whose
proposals draw
substantially on
their ERC funded
research.
European
Joint Programme on
Rare Diseases (EJP
RD)
Call
for Proposals 2022:
“Development of new
analytic tools and
pathways to
accelerate diagnosis
and facilitate
diagnostic
monitoring of rare
diseases”.
Funding organisation
in Spain: National
Institute of Health
Carlos III (ISCIII).
ERA
PerMeds JTC2022:
Prevention in
Personalised Medine
The
call aims to support
translational
research projects in
the field of
Personalised
Medicine (PM), to
encourage and enable
interdisciplinary
collaborations
towards
implementation of PM
and to encourage
collaboration
between academia,
clinical/public
health research and
SMEs.
Funding organisation
in Spain: National
Institute of Health
Carlos III (ISCIII)
and FCAECC.
JPIAMR
14th Call:
Disrupting Drug
Resistance Using
Innovative Design
Proposals
should focus on
licenced
antimicrobial agents
(antibiotics/antifungals) or agents under pre-clinical and/or early
clinical
development.
Funding organisation
in Spain: National
Institute of Health
Carlos III (ISCIII)
and Agencia Estatal
de Investigacion
(AEI).
MSCA
Staff Exchanges
promote innovative
international,
inter-sectoral and
interdisciplinary
collaboration in
research and
innovation through
exchanging staff and
sharing knowledge
and ideas at all
stages of the
innovation chain.
The scheme fosters a
shared culture of
research and
innovation that
welcomes and rewards
creativity and
entrepreneurship and
helps turn ideas
into innovative
products, services
or processes. It is
open to research,
technical,
administrative and
managerial staff
supporting R&I
activities.
The
ERC's grants operate
on a 'bottom-up'
basis looking for an
Excellence
Science.
Who can apply?
Researchers of any
nationality with 7-12
years of
experience since
completion of PhD.
Consolidator Grants
may be awarded up to
€ 2 million
for a period of
5 years.
Horizon
Europe – Digital,
Industry and Space
Cluster 2022 (1
stage)
HORIZON-CL4-2022-DIGITAL-EMERGING-01-35:
Advanced
characterization
methodologies to
assess and predict
the health and
environmental risks
of nanomaterials
(RIA)
APR
Horizon
Europe – Digital,
Industry and Space
Cluster 2022 (1
stage)
HORIZON-CL4-2022-DIGITAL-EMERGING-01-35:
Advanced
characterization
methodologies to
assess and predict
the health and
environmental risks
of nanomaterials
(RIA)
APR Full
proposal
Horizon
Europe - Health
Cluster 2022 (1
stage)
HLTH-2022-STAYHLTH-02-01:
Personalised
blueprint of chronic
inflammation in
health-to-disease
transition. HLTH-2022-ENVHLTH-04-01:
Methods for
assessing
health-related costs
of environmental
stressors. HLTH-2022-DISEASE-07-01:
Support for the
functioning of the
Global Research
Collaboration for
Infectious Disease
Preparedness
(GloPID-R). (CSA). HLTH-2022-DISEASE-07-02:
Pandemic
preparedness. HLTH-2022-DISEASE-07-03:
Non-communicable
diseases risk
reduction in
adolescence and
youth (Global
Alliance for Chronic
Diseases – GACD). HLTH-2022-DISEASE-03-01:
European partnership
fostering a European
Research Area (ERA)
for health research.
(COFUND). HLTH-2022-CARE-08-02:
Pre-commercial
research and
innovation
procurement (PCP)
for building the
resilience of health
care systems in the
context of recovery.
(PCP). HLTH-2022-CARE-08-03:
Public procurement
of innovative
solutions (PPI) for
building the
resilience of health
care systems in the
context of recovery.
(PPI). HLTH-2022-CARE-08-04:
Better financing
models for health
systems. (RIA). HLTH-2022-CARE-10-01:
European partnership
on transforming
health and care
systems. (COFUND). HLTH-2022-TOOL-11-01:
Optimising
effectiveness in
patients of existing
prescription drugs
for major diseases
(except cancer) with
the use of
biomarkers. (RIA). HLTH-2022-TOOL-11-02:
New methods for the
effective use of
real-world data
and/or synthetic
data in regulatory
decision-making
and/or in health
technology
assessment. (RIA). HLTH-2021-IND-13-01:
Enhancing
cybersecurity of
connected medical
devices. (RIA). HLTH-2021-IND-13-02:
Scaling up
multi-party
computation, data
anonymisation
techniques, and
synthetic data
generation. (RIA). HLTH-2021-IND-13-03:
New pricing and
payment models for
cost-effective and
affordable health
innovations. (RIA). HLTH-2021-IND-13-04:
Setting up a
European Smart
Health Innovation
Hub. (CSA). HLTH-2021-IND-13-05:
Setting up a
European Electronic
Health Record
Exchange Format
(EEHRxF) Ecosystem.
(CSA).
Nutrition-responsiveness
of the immune
system: interplay
between infectious
diseases and
diet-related
metabolic diseases
and the potential
for food-based
solutions
(NUTRIMMUNE).
HORIZON-MISS-2021-CANCER-02-01:
Develop new methods
and technologies for
cancer screening and
early detection.
(RIA). HORIZON-MISS-2021-CANCER-02-02:
Develop and validate
a set of quality of
life and patient
preference measures
for cancer patients
and survivors.
(RIA). HORIZON-MISS-2021-CANCER-02-03:
Better understanding
of the impact of
risk factors and
health determinants
on the development
and progression of
cancer. (RIA).
The
ERC's grants operate
on a 'bottom-up'
basis looking for an
Excellence
Science.
Who can apply?
Active researchers
who have a
track-record of
significant research
achievements in the
last 10 years.
Consolidator Grants
may be awarded up to
€ 2,5
million
for a period of 5
years.
NEURON
invites to the
open virtual meeting
“European Biomedical
Research Infrastructures’
resources for Researchers
in Neurosciences”
The 2-day-webinar is
organised by NEURON
(ISCIII partner) in
collaboration with EBRA
and will address the
different resources that
several European
Biomedical Research
Infrastructures, such as
ELIXIR, EBRAINS and
INFRAFRONTIER, can offer
to the researchers in
Neurosciences.
Date: 1st
& 3rd February 2022 Time:
Starting at 11:00 CET Registration:
No registration is
required.
Este
evento forma parte de los
Webinar de
preparación de
propuestas Advanced
Grant 2022,
cuya fecha final de
presentación es el próximo
28/04/2022.
En este primer webinario ERC
AdG 2022 se
indicarán las cuestiones
básicas de la convocatoria
brevemente: novedades
del WP2022, proceso,
paneles y criterios de
evaluación, formato de
la propuesta.
Para finalizar, se
dedicará un espacio de
media hora para resolver
colectivamente las dudas
que hayan podido surgir
sobre la convocatoria y
esta primera parte
curricular.
Este
evento forma parte de los
Webinar de preparación
de propuestas Advanced
Grant 2022,
cuya fecha final de
presentación es el próximo
28/04/2022.
En el segundo webinario
ERC AdG 2022 se
indicarán algunas pautas
para escribir
adecuadamente las
secciones dedicadas a la
propuesta: Abstract,
Section B1a y parte
curricular (Sections B1b
y B1c) y B2.
Para finalizar, se
dedicará un espacio de
media hora para resolver
colectivamente las dudas
que hayan podido surgir
sobre estas secciones.
Los talleres estarán
impartidos por las Puntos
Nacionales de Contacto
de ERC y
contarán con la presencia
del Representante
Nacional en el Comité de
Programa de ERC.
Hora:
10:00 – 12:00
Contacto
Instituto de Investigación
Sanitaria Aragón (IIS Aragón)
Centro de Investigación
Biomédica de Aragón (CIBA)
Avda. San Juan Bosco, nº 13.
50009 - Zaragoza
Tfno. +34 976 71 64 17 | +34 976
71 44 02
Recibes este boletín porque eres
miembro del IIS Aragón o porque
estás interesado en sus
actividades. Si no deseas
recibirlo, por favor, ponte en
contacto con internacional@iisaragon.es
para tramitar la baja de la
suscripción.
